Trustees of Princeton University Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$11.7M |
| 2 |
Spotify
SPOT
|
+$5.38M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$3.97M |
| 4 |
Teladoc Health
TDOC
|
+$2.5M |
| 5 |
CLDR
Cloudera, Inc.
CLDR
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 91.34% |
| 2 | Healthcare | 7.39% |
| 3 | Financials | 1.27% |
| 4 | Communication Services | 0% |
| 5 | Technology | 0% |
Similar funds
Trustees of Princeton University's Q3 2018 Portfolio in Review
As of Q3 2018, Trustees of Princeton University held 11 positions worth $71M, down 26% from $96.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trustees of Princeton University withdrew a net $25.7M in Q3 2018, closing 7 positions and reducing 2 holdings. Its most notable exit was Okta, an estimated $11.7M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 91% of assets, up from 67% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Trustees of Princeton University opened a new position in Rhythm Pharmaceuticals worth $1.39M.
- Trustees of Princeton University's largest Q3 2018 buy was Rhythm Pharmaceuticals: 47,643 shares worth $1.39M.
- Trustees of Princeton University's biggest Q3 2018 reduction was FinVolution Group, cutting an estimated $170K.
- Trustees of Princeton University fully exited Okta in Q3 2018, selling an estimated $11.7M.
- Trustees of Princeton University's ten largest holdings make up 100% of its $71M portfolio in Q3 2018.
- Trustees of Princeton University opened 1 new position and closed 7 in Q3 2018.
- Trustees of Princeton University's portfolio value fell 26% quarter-over-quarter to $71M.
Based on Trustees of Princeton University's 13F filing for Q3 2018, filed 14 Nov 2018.